NXL•Nexalin Technology received an extension to regain Nasdaq compliance, including meeting the $1 minimum bid price rule by Sept. 28, 2026, and restoring at least $2.5 million in stockholders’ equity by Jan. 4, 2027.
A Nasdaq hearings panel granted Nexalin Technology an extension to avoid delisting, conditional on the company regaining compliance with listing standards. Nexalin must maintain a bid price of at least $1 for 20 consecutive sessions by Sept. 28, 2026, and restore minimum stockholders’ equity of $2.5 million by Jan. 4, 2027. Failure to meet either deadline would trigger delisting risk.
